M Fodor

Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

Eric Van Cutsem, Vladimir Moiseyenko, Sergei Tjulandin et al. · Journal of Clinical Oncology · 2006 · 1.9K citations · Full text

Clinical Benefit With Docetaxel Plus Fluorouracil and Cisplatin Compared With Cisplatin and Fluorouracil in a Phase III Trial of Advanced Gastric or Gastroesophageal Adenocarcinoma: The V-325 Study Group

Jaffer A. Ajani, Vladimir Moiseyenko, Sergei Tjulandin et al. · Journal of Clinical Oncology · 2007 · 250 citations

Phase II Multi-Institutional Randomized Trial of Docetaxel Plus Cisplatin With or Without Fluorouracil in Patients With Untreated, Advanced Gastric, or Gastroesophageal Adenocarcinoma

Jaffer A. Ajani, M Fodor, Sergei Tjulandin et al. · Journal of Clinical Oncology · 2005 · 218 citations · Full text

Quality of Life With Docetaxel Plus Cisplatin and Fluorouracil Compared With Cisplatin and Fluorouracil From a Phase III Trial for Advanced Gastric or Gastroesophageal Adenocarcinoma: The V-325 Study Group

Jaffer A. Ajani, Vladimir Moiseyenko, Sergei Tjulandin et al. · Journal of Clinical Oncology · 2007 · 182 citations

A phase II study of gemcitabine in gallbladder carcinoma

J. O. Gallardo, B. Rubio, M Fodor et al. · Annals of Oncology · 2001 · 131 citations

Gallbladder Carcinoma, Biliary Tract, Medicine +4